相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。What is a promonocyte?
Barbara J. Bain
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: Prevalence, clinical correlates, and prognostic relevance
Mrinal M. Patnaik et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia
Eric Padron et al.
BLOOD (2013)
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet
Luca Malcovati et al.
BLOOD (2013)
The genetic basis of myelodysplasia and its clinical relevance
Mario Cazzola et al.
BLOOD (2013)
Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia
Esperanza Such et al.
BLOOD (2013)
Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia
Koichi Takahashi et al.
BLOOD (2013)
Clonal architecture of chronic myelomonocytic leukemias
Raphael Itzykson et al.
BLOOD (2013)
Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire
Sophie Park et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2013)
Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia
Sarah Abu Kar et al.
HAEMATOLOGICA (2013)
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
Raphael Itzykson et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML
R. R. Laborde et al.
LEUKEMIA (2013)
Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes
M. M. Patnaik et al.
LEUKEMIA (2013)
Treatment of chronic myelomonocytic leukemia with azacitidine
Eric Wong et al.
LEUKEMIA & LYMPHOMA (2013)
High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study
Luana Fianchi et al.
LEUKEMIA & LYMPHOMA (2013)
Predictive factors of response and survival among chronic myelomonocytic leukemia patients treated with azacitidine
Lionel Ades et al.
LEUKEMIA RESEARCH (2013)
SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value
Mrinal M. Patnaik et al.
BLOOD (2012)
Prognostic irrelevance of ring sideroblast percentage in World Health Organization-defined myelodysplastic syndromes without excess blasts
Mrinal M. Patnaik et al.
BLOOD (2012)
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
Manja Meggendorfer et al.
BLOOD (2012)
Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
Veronique Gelsi-Boyer et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2012)
Treatment of chronic myelomonocytic leukemia with 5-Azacitidine: A case series and literature review
Michael Thorpe et al.
LEUKEMIA RESEARCH (2012)
Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature
Rahel A. Mathew et al.
LEUKEMIA RESEARCH (2012)
Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia: Relapse-Free Survival Is Determined by Karyotype and Comorbidities
Hesham Eissa et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A
Anna M. Jankowska et al.
BLOOD (2011)
Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial
Thorsten Braun et al.
BLOOD (2011)
Activity of Azacitidine in Chronic Myelomonocytic Leukemia
Rubens Costa et al.
CANCER (2011)
Cytogenetic risk stratification in chronic myelomonocytic leukemia
Esperanza Such et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Phase I Study of Oral Azacitidine in Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia
Guillermo Garcia-Manero et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms
O. Abdel-Wahab et al.
LEUKEMIA (2011)
Frequent pathway mutations of splicing machinery in myelodysplasia
Kenichi Yoshida et al.
NATURE (2011)
Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experience
P. Krishnamurthy et al.
BONE MARROW TRANSPLANTATION (2010)
RAS Mutations Contribute to Evolution of Chronic Myelomonocytic Leukemia to the Proliferative Variant
Clara Ricci et al.
CLINICAL CANCER RESEARCH (2010)
Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1
Alexander Kohlmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) in Single and Multiple Institutions: Limitations and Inferences
Mohamed L. Sorror et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Outcome of allo-SCT for chronic myelomonocytic leukemia
S. Ocheni et al.
BONE MARROW TRANSPLANTATION (2009)
Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia
Veronique Gelsi-Boyer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Therapy related CMML: a case report and review of the literature
Faheem Ahmed et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2009)
RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation
M-C Kuo et al.
LEUKEMIA (2009)
Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System
Hagop Kantarjian et al.
CANCER (2008)
On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia
E. J. Feldman et al.
LEUKEMIA (2008)
Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML)
P. W. Wijermans et al.
LEUKEMIA RESEARCH (2008)
Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemia
Ahmed Aribi et al.
CANCER (2007)
Prognostic factors and risk assessment in chronic myelomonocytic leukemia: Validation study of the M. D. Anderson prognostic scoring system
Miloslav Beran et al.
LEUKEMIA & LYMPHOMA (2007)
Oncogenes in myeloproliferative disorders
Ayalew Tefferi et al.
CELL CYCLE (2007)
Activity of 9-nitro-camptothecin, an oral topoisomerase I inhibitor, in myelodysplastic syndrome and chronic myelomonocytic leukemia
Alfonso Quintas-Cardama et al.
CANCER (2006)
FIP1L1-PDGFRA in eosinophilic disorders:: Prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature
A. Pardanani et al.
LEUKEMIA RESEARCH (2006)
Chronic myelomonocytic leukaemia after platinum-based therapy for non-small cell lung cancer: case report and review of the literature
K. B. Kim et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2006)
Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia
M Elliott et al.
BONE MARROW TRANSPLANTATION (2006)
Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia
P Mittal et al.
BONE MARROW TRANSPLANTATION (2004)
Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta
JF Apperley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
To the editor: New prognostic parameters for chronic myelomonocytic leukemia?
U Germing et al.
BLOOD (2002)
Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia.: A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
N Kröger et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients
F Onida et al.
BLOOD (2002)
A phase-II trial of all trans retinoic acid and low-dose cytosine arabinoside for the treatment of high-risk myelodysplastic syndromes
A Venditti et al.
ANNALS OF HEMATOLOGY (2000)
分享论文
